RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Birmingham, AL · +121 more sites
Psoriasis clinical trials in Birmingham, AL
7 recruiting psoriasis studies with a site in Birmingham, AL.
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Birmingham, AL · +50 more sites
RecruitingPhase 3NCT06979453
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Sponsor: Bristol-Myers Squibb
Birmingham, AL · +45 more sites
RecruitingPhase not listedNCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Sponsor: Duke University
Birmingham, AL · +74 more sites
RecruitingPhase 3NCT07219420
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Sponsor: UCB Biopharma SRL
Birmingham, AL · +7 more sites
RecruitingPhase 2NCT07489885
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Sponsor: InventisBio Co., Ltd
Birmingham, AL · +19 more sites
RecruitingPhase not listedNCT03125655
Regulation of Inflammatory Genes in Psoriasis
Sponsor: University of Alabama at Birmingham
Birmingham, AL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.